Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05040932
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Eucure (Beijing) Biopharma Co., Ltd 8
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Early research (Phase 1)Study completedNCT01307267
What this trial is testing

PF-05082566 As A Single Agent And In Combination With Rituximab

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more
Pfizer 190
Testing effectiveness (Phase 2)Looking for participantsNCT05751798
What this trial is testing

Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Solid Advanced TumorLymphomaNSCLC (Non-small Cell Lung Cancer)
OSE Immunotherapeutics 41
Early research (Phase 1)Study completedNCT03061188
What this trial is testing

Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma

Who this might be right for
Advanced Solid NeoplasmAggressive Non-Hodgkin LymphomaRecurrent Solid Neoplasm+3 more
Northwestern University 15
Early research (Phase 1)Ended earlyNCT04281420
What this trial is testing

Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid Tumor, Non-Hodgkin's Lymphoma
Antengene Therapeutics Limited 20
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00364676
What this trial is testing

Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
TumorsHodgkins DiseaseNon-Hodgkins Lymphoma
Spectrum Pharmaceuticals, Inc 67
Testing effectiveness (Phase 2)UnknownNCT04983810
What this trial is testing

Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

Who this might be right for
Solid Tumor, AdultLymphoma
Cyclacel Pharmaceuticals, Inc. 330
Testing effectiveness (Phase 2)Looking for participantsNCT02332668
What this trial is testing

Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Who this might be right for
MelanomaLymphomaSolid Tumor+2 more
Merck Sharp & Dohme LLC 370
Early research (Phase 1)Study completedNCT00522652
What this trial is testing

Phase I Trial of PX-478

Who this might be right for
Advanced Solid TumorsLymphoma
Cascadian Therapeutics Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT04104776
What this trial is testing

Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more
Novartis Pharmaceuticals 300
Early research (Phase 1)UnknownNCT05650580
What this trial is testing

TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors

Who this might be right for
Non-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma RefractoryAdvanced Solid Tumor
Tarapeutics Science Inc. 26
Early research (Phase 1)Looking for participantsNCT05892718
What this trial is testing

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Who this might be right for
Advanced Solid TumorRefractory Non-Hodgkin Lymphoma
FBD Biologics Limited 80
Early research (Phase 1)Looking for participantsNCT05341557
What this trial is testing

BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Who this might be right for
Advanced Solid TumorLymphomaNSCLC+1 more
Betta Pharmaceuticals Co., Ltd. 110
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT02702492
What this trial is testing

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

Who this might be right for
Solid TumorsNHL
Karyopharm Therapeutics Inc 60
Early research (Phase 1)Study completedNCT01284192
What this trial is testing

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Who this might be right for
Advanced MalignanciesPositive for Anaplastic Lymphoma KinasePositive for Proto-Oncogene Tyrosine-Protein Kinase ROS+2 more
Astellas Pharma Inc 46
Early research (Phase 1)WithdrawnNCT04372641
What this trial is testing

Testing the Safety of CB-5339 in Patients With Cancer

Who this might be right for
Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaLocally Advanced Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02018874
What this trial is testing

A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine

Who this might be right for
Solid Tumors and Non-Hodgkin's Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 52
Next Page